U

FutureWorld Corp. FWDG

OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

Company Overview

FutureWorld Corp. (OTC: FWDG) is a micro-cap holding company that has historically focused on emerging technology, health sciences, and cannabis-related commercial opportunities. Public disclosures and OTC market filings indicate that the company has pursued business models tied to biotechnology, hemp-derived products, intellectual property development, and technology commercialization. Available records suggest that the company has operated primarily through acquisitions, licensing arrangements, and strategic investments rather than through a large-scale standalone operating platform.

The company’s historical positioning centered on identifying early-stage sectors with perceived long-term growth potential, particularly in cannabis therapeutics, industrial hemp, and related intellectual property applications. Publicly available information indicates that FutureWorld evolved through a series of restructurings and strategic pivots common among OTC-listed development-stage companies. Data regarding current large-scale commercial operations, audited financial scale, and sustained recurring revenue remains limited in recent public disclosures, and some operational details are inconclusive based on available public sources.

Business Operations

FutureWorld Corp.’s reported activities have historically included technology licensing, cannabis and hemp-related product development, and investment-oriented corporate structuring. Public filings and OTC disclosures reference activities associated with cannabinoids, nutraceutical concepts, and intellectual property initiatives tied to medical or agricultural applications. The company has also explored partnerships and subsidiary structures intended to commercialize products in regulated cannabis-adjacent markets. However, publicly verifiable information regarding active revenue-generating business units is limited.

The company’s operations appear to have been concentrated primarily within the United States, with strategic references to broader international market opportunities in cannabis and biotechnology sectors. Historical disclosures referenced relationships with research and commercialization entities, though the long-term operational status and financial contribution of several initiatives remain unclear. Data concerning major active subsidiaries, material joint ventures, and large-scale operating assets is inconclusive based on available public sources and recent SEC-linked disclosures.

Strategic Position & Investments

FutureWorld Corp.’s strategic direction has historically focused on participation in emerging industries with regulatory and technological growth potential, particularly cannabis-derived therapeutics, hemp-related products, and intellectual property commercialization. Prior company communications and market disclosures indicate interest in acquisitions, licensing agreements, and strategic investments designed to establish an early presence in developing sectors rather than competing as a large integrated operator.

Public records also suggest that the company explored opportunities tied to biotechnology innovation and alternative health products. Certain historical announcements referenced partnerships and acquisitions involving cannabis-related research or commercialization entities, though independently verifiable details regarding financial impact, integration outcomes, or continuing operations are limited. Information concerning currently active portfolio companies, material investment holdings, or proprietary technologies remains incomplete in publicly accessible filings.

Geographic Footprint

FutureWorld Corp. has historically operated primarily within the United States, with corporate activity associated with OTC market participation and U.S.-based regulatory frameworks tied to cannabis and hemp industries. Public disclosures indicate that the company targeted sectors with potential international applicability, particularly where cannabis regulation and biotechnology commercialization were expanding.

The company’s operational footprint appears limited relative to larger publicly traded multinational firms. While historical statements referenced broader market opportunities and potential international partnerships, publicly verifiable evidence of substantial operating infrastructure outside the United States is limited. Data regarding material overseas assets, regional operating hubs, or significant international revenue exposure is inconclusive based on available public sources.

Leadership & Governance

Publicly available governance information for FutureWorld Corp. has varied over time, reflecting management changes and limited reporting continuity typical of certain OTC-listed companies. Historical filings and disclosures indicate leadership structures centered around corporate restructuring, strategic investment evaluation, and business development in emerging sectors. Due to inconsistent and dated public reporting, some executive and board information cannot be independently verified through current filings.

Known or historically referenced executives associated with the company include:

  • Timothy E. Matula – Former Chief Executive Officer
  • Juan M. Villalobos – Former executive leadership role associated with company operations
  • Scott Miller – Historical management association referenced in public disclosures

The company’s stated strategic philosophy historically emphasized identifying early-stage commercial opportunities in regulated and innovation-driven industries. However, current governance structure, executive continuity, and active operational leadership are not fully verifiable through recent publicly available filings.

Data compiled by narrative technology. May contain errors.

Top Tech Stocks
See All »
B
NVDA NASDAQ $228.87
B
AAPL NASDAQ $339.75
B
AVGO NASDAQ $364.54
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $110.12
A
Top Financial Stocks
See All »
B
B
JPM NYSE $340.00
B
V NYSE $362.04
Top Health Care Stocks
See All »
B
LLY NYSE $1,170.14
B
JNJ NYSE $269.19
B
ABBV NYSE $265.21
Top Real Estate Stocks
See All »
B
PLD NYSE $135.88
B
EQIX NASDAQ $1,059.26